‘Critically Ill’ Coronavirus Patient Saved By Stem Cell Therapy, Study Says

Clinical support technician Douglas Condie extracts viruses from swab samples so that the genetic structure of a virus can be analysed and identified in the coronavirus testing laboratory at Glasgow Royal Infirmary, on February 19, 2020 in Glasgow, Scotland.
Jane Barlow - WPA Pool / Getty Images

The life of a critically ill 65-year-old woman being treated at China‘s Kunming University hospital intensive care unit with coronavirus was saved after receiving stem cell therapy, South China Morning Post reports.

According to a study published Thursday on Chinaxiv.org., the woman was treated at Baoshan Hospital in Kunming, the capital of southwest China’s Yunnan province. After contracting coronavirus, the patient reportedly fought for her life for almost two weeks until she received a shot of umbilical cord stem cells. Four days after receiving the injection, she was said to be able to walk again.

“Although only one case was shown here, it could be very important and inspire similar clinical practices in treating critically ill Covid-19 patients,” the study, which has yet to be peer-reviewed, revealed.

The woman reportedly experienced no ill effects from the therapy, and the study suggests treatment might be best used in combination with “other immune-modulating agents.”

The World Health Organization (WHO) lists 14 trials of stem cell treatment for Covid-19 in its clinical database. Although this particular form of therapy is controversial, stem cell therapy has shown promise for critically ill patients, generating hope among health and medical professionals.

Dr. Li Honghui has pushed the use of stem cell therapy, highlighting its potential to show results within days.

“We cannot stick to the rules, we must be bold and innovative,” he said, per Hunan Daily.

As reported by Business Insider, coronavirus treatment could become expensive in the United States. A Thursday report released by America’s Health Insurance Plans (AHIP) claimed that the Centers for Disease Control and Prevention (CDC) is currently the only facility allowed to test for the virus while not being billed for these efforts. For Americans treated in the ER or urgent care, other fees will likely rack up, depending on the insurance plan held by the individual.

As The Inquisitr previously reported, former Food and Drug Administration (FDA) Commissioner, Scott Gottlieb, claimed that the United States would have a screening capacity of 10,000 people by the end of next week, and another 10,000 by the end of the following week. He has also pushed for a virus response that includes outreach to manufacturers able to help with diagnosis, ensuring that testing does not only rely on the CDC.

“What we need to do now is make a real concerted effort to get a therapeutic,” he said, per The Hill. “We know when [coronavirus] started but we don’t know when this is going to end.”